CoChat

Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Depression is experienced as a persistent low mood or anhedonia accompanied by behavioural and cognitive disturbances which impair day to day functioning. However, the diagnosis is largely based on self-reported symptoms, and there are no neurobiological markers to guide the choice of treatment. In the present study, we examined the prognostic and diagnostic potential of the structural neural correlates of depression. METHODOLOGY AND PRINCIPAL FINDINGS: Subjects were 37 patients with major depressive disorder (mean age 43.2 years), medication-free, in an acute depressive episode, and 37 healthy individuals. Following the MRI scan, 30 patients underwent treatment with the antidepressant medication fluoxetine or cognitive behavioural therapy (CBT). Of the patients who subsequently achieved clinical remission with antidepressant medication, the whole brain structural neuroanatomy predicted 88.9% of the clinical response, prior to the initiation of treatment (88.9% patients in clinical remission (sensitivity) and 88.9% patients with residual symptoms (specificity), p = 0.01). Accuracy of the structural neuroanatomy as a diagnostic marker though was 67.6% (64.9% patients (sensitivity) and 70.3% healthy individuals (specificity), p = 0.027). CONCLUSIONS AND SIGNIFICANCE: The structural neuroanatomy of depression shows high predictive potential for clinical response to antidepressant medication, while its diagnostic potential is more limited. The present findings provide initial steps towards the development of neurobiological prognostic markers for depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0006353

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sagittal cross-sectional view of regions pertinent for diagnosis and prediction of treatment response in depression. In the top panel, sagittal views are presented which show medial regions of decreased grey matter density which contributed to the diagnosis of depression (coloured in green) in the right subgenual anterior cingulate (BA 25) and precuneus (BA 7). No regions of increased grey matter in patients with depression relative to healthy individuals contributed to the diagnosis. In the lower panel, increased grey matter density in the anterior and posterior cingulate cortices (red) increased the probability of clinical remission to treatment with the antidepressant medication fluoxetine. Greater density in the orbitofrontal cortex (blue) increased the odds of residual symptoms of depression following antidepressant medication. Regions depicted were selected as relevant to the classification of patients as achieving remission or non-remission clinical status following fluoxetine treatment by every cross-validated support vector machine classification model. Sagittal views are presented in MNI space at z = −4, 10, 12 and 14.
Figure 1 Sagittal cross-sectional view of regions pertinent for diagnosis and prediction of treatment response in depression. In the top panel, sagittal views are presented which show medial regions of decreased grey matter density which contributed to the diagnosis of depression (coloured in green) in the right subgenual anterior cingulate (BA 25) and precuneus (BA 7). No regions of increased grey matter in patients with depression relative to healthy individuals contributed to the diagnosis. In the lower panel, increased grey matter density in the anterior and posterior cingulate cortices (red) increased the probability of clinical remission to treatment with the antidepressant medication fluoxetine. Greater density in the orbitofrontal cortex (blue) increased the odds of residual symptoms of depression following antidepressant medication. Regions depicted were selected as relevant to the classification of patients as achieving remission or non-remission clinical status following fluoxetine treatment by every cross-validated support vector machine classification model. Sagittal views are presented in MNI space at z = −4, 10, 12 and 14.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 1

  1. [29]American Psychiatric Association 1994 Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) Washington DC APA Press

Cited by

See all 232

Metadata

Authors
Costafreda, S. G., Chu, C., Ashburner, J., & Fu, C. H. Y.
Affiliations
  • King's College London (GB)
  • Wellcome Centre for Human Neuroimaging (GB)
Corresponding author
Fu, Cynthia H. Y.
Venue
PLoS ONE
Published
2009-07-27
Volume
4
Issue
7
Pages
e6353
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2115449759
Cited by
232
References
42
Citations by year
2026: 1 · 2025: 7 · 2024: 4 · 2023: 3 · 2022: 12 · 2021: 13 · 2020: 15 · 2019: 21 · 2018: 16 · 2017: 18 · 2016: 14 · 2015: 24 · 2014: 25 · 2013: 19 · 2012: 19
FWCI
9.24
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UEL Research Repository (University of East London) (acceptedVersion)
  • UEL Research Repository (University of East London) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, neuroimaging biomarkers, treatment response prediction, antidepressant response, fluoxetine, cognitive behavioral therapy, clinical remission, diagnostic accuracy, neurobiological markers
MeSH terms
Adult, Combined Modality Therapy, Depression, Female, Fluoxetine, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prognosis, Cognitive Behavioral Therapy, Case-Control Studies, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression. https://app.cochat.ai/papers/10.1371/journal.pone.0006353
The paper
Costafreda, S. G., Chu, C., Ashburner, J., & Fu, C. H. Y. (2009). Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression. PLoS ONE. https://doi.org/10.1371/journal.pone.0006353

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.